| Product NDC: | 0003-2328 |
| Proprietary Name: | YERVOY |
| Non Proprietary Name: | ipilimumab |
| Active Ingredient(s): | 5 mg/mL & nbsp; ipilimumab |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0003-2328 |
| Labeler Name: | E.R. Squibb & Sons, L.L.C. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125377 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20110325 |
| Package NDC: | 0003-2328-22 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0003-2328-22) > 200 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 0003-2328-22 |
| Proprietary Name | YERVOY |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0003-2328-22) > 200 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0003-2328 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ipilimumab |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110325 |
| Marketing Category Name | BLA |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | IPILIMUMAB |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |